WeRide Inc. — Share Issue/Capital Change 2003

Oct 8, 2003

The Stock Exchange of Hong Kong Limited takes no responsibility for the contents of this announcement, makes no representation as to its accuracy or completeness and expressly disclaims any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

FAR EAST PHARMACEUTICAL TECHNOLOGY COMPANY LIMITED （遠東生物制藥科技有限公司）

(Incorporated in the Cayman Islands with limited liability)

PROPOSAL FOR SUBDIVISION OF SHARES AND CHANGE IN BOARD LOT SIZE OF SHARES

• The Board proposes that each of the existing issued and unissued Shares of HK$0.10 each in the share capital of the Company be subdivided into four Subdivided Shares of HK$0.025 each. The Share Subdivision is subject to, inter alia, Shareholders’ approval. The expected timetable for the implementation of the Share Subdivision and the associated trading arrangements are set out below.

• The Shares are now traded on the Stock Exchange in board lots of 2,000 Shares. Following the implementation of the Share Subdivision, the board lot size will be changed to 4,000 Subdivided Shares.

PROPOSED SHARE SUBDIVISION AND CHANGE IN BOARD LOT SIZE

The board of directors (the “Board”) of Far East Pharmaceutical Technology Company Limited (the “Company”) proposes that each of the existing issued and unissued shares of HK$0.10 each in the share capital of the Company (the “Shares”) be subdivided (the “Share Subdivision”) into four shares of HK$0.025 each (the “Subdivided Shares”). Currently, the Shares are traded in board lots of 2,000 Shares. Following the implementation of the Share Subdivision, the board lot size will be changed to 4,000 Subdivided Shares for the purpose of trading on The Stock Exchange of Hong Kong Limited (the “Stock Exchange”).

1

Far East Pharmaceutical Technology Company Limited – Announcement

7 October, 2003

As at the date of this announcement, the authorised share capital of the Company was HK$100,000,000 which was divided into 1,000,000,000 Shares, of which 508,935,600 Shares were in issue. Immediately following the implementation of the Share Subdivision, (i) the authorised share capital of the Company will be HK$100,000,000 which is divided into 4,000,000,000 Subdivided Shares and (ii) 2,035,742,400 Subdivided Shares will be in issue assuming that no Shares are issued or purchased by the Company prior to the implementation of the Share Subdivision.

Reasons for the Share Subdivision

The Board considers that upon the Share Subdivision having become effective, the monetary value of each board lot of the Subdivided Shares will be less than the value of the existing board lot of the Shares. The Board believes a lower board lot value would make the shares of the Company more assessable to a wider range of investors and would in turn improve the liquidity in trading of the Subdivided Shares. Such improvement would enable the shareholders of the Company (the “Shareholders”) to acquire or dispose of their shareholdings in the Company more efficiently which, in general, is regarded as advantageous to the Shareholders.

Effects of the Share Subdivision

The Subdivided Shares will rank pari passu in all respects with each other and the Share Subdivision will not result in any change in the relevant rights of the Shareholders.

Save for the expenses to be incurred in relation to the Share Subdivision, the Board believes that the implementation of the Share Subdivision will not, by itself, alter the net asset value, business operations, management or financial position of the Group or the proportionate interest of Shareholders in the Company.

Adjustment to the outstanding share options

As at the date of this announcement, the Company has 52,000,000 outstanding share options. In accordance with the terms of the share option schemes of the Company, Share Subdivision may result in adjustments to the subscription price and/or the number of shares of the Company to be subscribed for in relation to the outstanding share options. A notice regarding such adjustments will be served on holders of the outstanding share options when the Share Subdivision becomes unconditional.

2

Far East Pharmaceutical Technology Company Limited – Announcement

7 October, 2003

Conditions of Share Subdivision

The Share Subdivision is conditional upon (a) the passing of an ordinary resolution approving the Share Subdivision by the Shareholders at an extraordinary general meeting of the Company (the “Extraordinary General Meeting”); and (b) the Listing Committee of the Stock Exchange granting the listing of, and permission to deal in, the Subdivided Shares in issue and any new Subdivided Shares which may fall to be issued pursuant to the exercise of options granted under the Company’s share option scheme.

EXPECTED TIMETABLE

Year 2003

Despatch of circular in relation to the Share Subdivision

and associated trading arrangements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Friday, 10 October

Latest time for lodging of form of proxy for the Extraordinary General Meeting . . . . . . . . . . . . . . . . . 3:00 p.m. on Saturday, 25 October

Extraordinary General Meeting to approve

the Share Subdivision . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3:00 p.m. on Monday, 27 October

Effective date of the Share Subdivision . . . . . . . . . . . . . . . . . . . . . . . . . . . . Tuesday, 28 October

Dealing in Subdivided Shares commences. . . . . . . . . . . . . . . 9:30 a.m. on Tuesday, 28 October

Original counter for trading in existing Shares

in board lots of 2,000 Shares closes . . . . . . . . . . . . . . . . . . 9:30 a.m. on Tuesday, 28 October

Temporary counter for trading in Subdivided Shares

in board lots of 8,000 Subdivided Shares

(in the form of existing share certificates) opens . . . . . . . 9:30 a.m. on Tuesday, 28 October

First day for free exchange of certificates for existing

Shares for new certificates for Subdivided Shares . . . . . . . . . . . . . . . . . Tuesday, 28 October

3

Far East Pharmaceutical Technology Company Limited – Announcement

7 October, 2003

Original counter for trading in Subdivided Shares

in board lots of 4,000 Subdivided Shares

(in the form of new certificates

for Subdivided Shares) re-opens . . . . . . . . . . . . . . . . . . . 9:30 a.m. on Tuesday, 11 November

Parallel trading in Subdivided Shares

(in the form of (a) new certificates for Subdivided Shares and (b) certificates

for existing Shares) commences . . . . . . . . . . . . . . . . . . . 9:30 a.m. on Tuesday, 11 November

Temporary counter for trading in Subdivided Shares

in board lots of 8,000 Subdivided Shares

(in the form of existing share certificates) closes . . . . . . 4:00 p.m. on Tuesday, 2 December

Parallel trading in Subdivided Shares

(in the form of (a) new certificates for Subdivided Shares and (b) certificates

for existing Shares) ends . . . . . . . . . . . . . . . . . . . . . . . . . . 4:00 p.m. on Tuesday, 2 December

Latest time for free exchange of certificates

for existing Shares for new certificates

for Subdivided Shares . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4:30 p.m. on Friday, 5 December

Every existing certificate will only be valid for delivery and settlement purposes for the period up to 3:45 p.m. on 4 December 2003 and thereafter will not be accepted for settlement purposes. However, the certificates for existing Shares will continue to be good evidence of legal title to the Subdivided Shares on the basis of one existing Share for four Subdivided Shares.

Subject to the Share Subdivision becoming effective, Shareholders may, during business hours from Tuesday, 28 October 2003 to Friday, 5 December 2003 (both dates inclusive), submit their certificates for the Shares to the Company’s share registrar, Tengis Limited at G/F, Bank of East Asia Harbour View Centre, 56 Gloucester Road, Wanchai, Hong Kong in exchange for certificates for the Subdivided Shares (on the basis of every one Share for four Subdivided Shares) free of charge. Thereafter, share certificates for Shares will be accepted for exchange only on payment of a fee of HK$2.50 (or such higher amount as may from time to time be specified by the Stock Exchange) for each new certificate issued for the Subdivided Shares or each old share certificate submitted, whichever number of share certificate involved is higher.

4

Far East Pharmaceutical Technology Company Limited – Announcement

7 October, 2003

GENERAL

Application will be made to the Stock Exchange for the listing of, and permission to deal in, the Subdivided Shares in issue and any new Subdivided Shares which may fall to be issued pursuant to the exercise of options granted under the Company’s share option scheme.

A circular containing, among other things, details of the Share Subdivision and the associated trading arrangements and a notice convening the Extraordinary General Meeting will be despatched to the Shareholders on 10 October 2003.

By Order of the Board Cai Chong Zhen Chairman

Hong Kong, 7 October 2003

Please also refer to the published version of this announcement in The Standard.

5

Far East Pharmaceutical Technology Company Limited – Announcement

7 October, 2003